Untitled Quiz
18 Questions
0 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

What is a primary advantage of peptide vaccines compared to protein-containing subunit vaccines?

  • They are less expensive and purer. (correct)
  • They induce a broader immune response.
  • They stimulate B cell activation effectively.
  • They require more purification steps.
  • What is a notable characteristic of DNA vaccines compared to traditional methods of vaccine production?

  • They can be modified easily in laboratories. (correct)
  • They require complex purification processes.
  • They do not allow for gene modifications.
  • They only produce cellular immunity without B cell responses.
  • What immune response is primarily generated by the expression of antigenic protein within the APCs through DNA vaccines?

  • Production of cytotoxic CD8 T cells. (correct)
  • Innate immunity.
  • Humoral immunity.
  • Weak immune activation.
  • What issue is commonly encountered in the application of DNA vaccines in humans, despite successful animal models?

    <p>General lack of potency.</p> Signup and view all the answers

    Why are adjuvants often used in combination with DNA vaccines?

    <p>To improve the method of administering DNA.</p> Signup and view all the answers

    What was a significant finding from the clinical trial of an antimalarial DNA vaccine?

    <p>It displayed no effect even after boosters.</p> Signup and view all the answers

    What does the process of antigen gene expression within APCs allow for in DNA vaccines?

    <p>It favors the development of cytotoxic T cells.</p> Signup and view all the answers

    What is a challenge with using peptides for B cell stimulation?

    <p>Peptides can generate strong cellular immunity instead.</p> Signup and view all the answers

    What is the primary role of adjuvants in subunit vaccines?

    <p>To enhance and prolong the immune response</p> Signup and view all the answers

    Why do polysaccharide vaccines require carrier proteins?

    <p>To provide T cell epitopes</p> Signup and view all the answers

    What is a significant advantage of live, attenuated vaccines over killed vaccines?

    <p>They can multiply within the host</p> Signup and view all the answers

    Which feature of the hepatitis B surface antigen is utilized to enhance vaccine effectiveness?

    <p>Its ability to self-assemble into larger particles</p> Signup and view all the answers

    What was the outcome of replacing L-alanine with L-threonine in synthetic adjuvant design?

    <p>Potent stimulation of immune response</p> Signup and view all the answers

    How do adjuvants like monophosphoryl lipid A function?

    <p>By interacting with specific immune receptors</p> Signup and view all the answers

    What characteristic of whole pathogens contributes to their stronger immune response compared to pure subunit vaccines?

    <p>Their complexity and size</p> Signup and view all the answers

    What is the main purpose of using recombinant DNA techniques in vaccine design?

    <p>To fuse important parts of antigens together</p> Signup and view all the answers

    Why are small peptide vaccines attached to carrier proteins?

    <p>To enhance their stability and immunogenicity</p> Signup and view all the answers

    Which of the following is a common characteristic of subunit vaccines?

    <p>They use only specific macromolecular components</p> Signup and view all the answers

    Study Notes

    Recombinant and Synthetic Vaccines III

    • Vaccine antibody production requires both B cell and T cell epitopes.
    • Subunit protein vaccines, being large proteins, contain both.
    • Polysaccharide vaccines present a limitation—they lack T cell epitopes.
    • To address this, carrier proteins are utilized.
    • This creates conjugate vaccines capable of immunizing infants effectively.

    Improving the Effectiveness of Subunit Vaccines

    • Strongest immune responses occur with concentrated antigens.

    • Pure subunit vaccines generally produce weaker responses than whole pathogens.

    • Hepatitis B and human papillomavirus surface antigens uniquely assemble into particles similar to empty virus particles.

    • Various methods fix numerous antigenic protein molecules onto particulate carrier surfaces.

    • Insoluble aluminum salts act as adjuvants.

      • They maintain high immunogen concentration locally.
      • This ensures effective presentation of antigens.
    • MF59, an oil-in-water emulsion, is a new adjuvant.

      • It contains squalene and detergents.
      • Amphiphilic immunogens concentrate at the oil/water interface.
      • This assists in the creation of effective influenza vaccines.
    • Another approach enhances subunit antigens by using the hepatitis B surface antigen's self-assembling property.

    • This involves fusing other subunit antigens to the hepatitis B surface antigen.

    • Recombinant DNA technique (genetic engineering) is central to this method.

    • Adjuvants that interact with Toll-like receptors are utilized.

    • Synthetic analogs of the natural adjuvant muramyldipeptide (MDP) have been explored.

      • MDP is a fragment of bacterial peptidoglycan.
      • Modifications (e.g., replacing L-alanine with L-threonine) are made to avoid unwanted side effects.
      • This helps achieve potent immune responses.
    • Another type of adjuvant—monophosphoryl lipid A and its derivatives—interact with Toll-like receptors.

    • These compounds share structural similarities with LPS (specifically its lipid portion, lipid A) but are significantly less toxic.

    Use of Live, Attenuated Vectors

    • Live, attenuated vaccines introduce subunit antigens into live, attenuated viruses or bacteria.
    • This approach often confers stronger, longer-lasting immunity than killed vaccines.
    • Live vaccines are typically delivered in lower doses compared to killed vaccines; they can multiply within the host.

    Fragments of Antigen Subunit Used as Synthetic Peptide Vaccines

    • Subunit vaccines utilize one or a few macromolecular components of the pathogen.
    • Only the most critical parts (epitopes) of the pathogen are needed for proper binding.
    • This approach permits the targeting of desired epitopes and allows greater control of the immune response.
    • Peptides are usually attached to macromolecular carrier proteins before administration.

    Peptide Vaccine Advantages

    • Peptides can be chemically synthesized.
    • Less purification is required compared to recombinant subunit-based vaccines.
    • Purification is often difficult and expensive.
    • This makes peptide vaccines more cost-effective, pure, and stable.
    • Peptides play a role in generating cellular immunity by selecting T cell clones.

    DNA Vaccines

    • Injected DNA into mice resulted in foreign gene expression.
    • This suggests potential gene expression in animals.
    • Plasmid DNA containing pathogen antigen genes creates immunity.
    • DNA vaccines are easily modified, facilitating the production of new and tailored vaccines.
    • Steps needed for conventional protein vaccines, like purification, are less critical with DNA vaccines.
    • The antigen gene in DNA vaccines can be expressed within antigen-presenting cells (APCs).
    • This means immune response is strongly directed towards cytotoxic CD8 T cells.

    DNA Vaccine Mechanisms of Action

    • Foreign DNA from pathogens is transcribed, and translated into protein by cells, resulting in presentation of these foreign antigens.
    • Cells (especially APCs and T cells) then interact, leading to an immune response.

    DNA Vaccine Success in Humans

    • Significant research focuses on creating effective DNA vaccines.
    • Initial successes were observed, but DNA vaccines are often not potent enough for use in humans.
    • Increasing potency is a major research focus.
      • By enhancing the introduction method.
      • Combining initial DNA vaccine delivery with subsequent booster shots.
    • Despite this, recent clinical trials using antimalarial DNA vaccines showed no effect even with boosters.

    DNA Vaccine Dosage Considerations

    • Initial research in mice utilized much higher doses than appropriate for humans.
    • Larger human doses are impractical to administer and produce.
      • Manufacturing large amounts is expensive.
    • Current human trial usage is significantly lower than those used in initial mouse tests.
    • Research focuses on determining optimal doses.

    Novel Approaches for DNA Vaccines

    • Additional strategies are being explored to improve DNA vaccine effectiveness and safety.
    • One possible consideration is the integration of foreign plasmid DNA into human chromosomes.
    • While this risk is theoretically low, experiments have shown that successful vaccines will be administered to massive populations, even billions, in which scenario, any potential adverse events must be viewed seriously.

    Studying That Suits You

    Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

    Quiz Team

    Related Documents

    More Like This

    Untitled Quiz
    6 questions

    Untitled Quiz

    AdoredHealing avatar
    AdoredHealing
    Untitled Quiz
    37 questions

    Untitled Quiz

    WellReceivedSquirrel7948 avatar
    WellReceivedSquirrel7948
    Untitled Quiz
    55 questions

    Untitled Quiz

    StatuesquePrimrose avatar
    StatuesquePrimrose
    Untitled Quiz
    18 questions

    Untitled Quiz

    RighteousIguana avatar
    RighteousIguana
    Use Quizgecko on...
    Browser
    Browser